Table 3.

Number of patients reaching the study end point and time when the study end point was reached

M-Type Phospholipase A2 Receptor Autoantibody Level at Study InclusionNumber of Patients Reaching the Study End Point (%)Mean Time (mo) to Reach Study End Point
Time95% Confidence Interval
Tertile 1 (20–86 units/ml)10 (25)30.927.1 to 34.7
Tertile 2 (87–201 units/ml)22 (56)26.922.0 to 31.8
Tertile 3 (≥202 units/ml)27 (69)17.714.1 to 21.2
Overall59 (50)26.924.0 to 29.8